Related Experiment Video
Updated: Oct 15, 2025

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
Critical Role of Caveolin-1 Loss/Dysfunction in Pulmonary Hypertension
1Section of Pediatric Cardiology, Departments of Pediatrics and Physiology, New York Medical College, Valhalla, NY 10595, USA.
Pulmonary hypertension (PH) involves endothelial cell disruption and loss of caveolin-1, promoting vascular remodeling and disease progression. Hypoxia-induced PH shows caveolin-1 dysfunction without endothelial damage, and is reversible.
Area of Science:
- Cardiovascular Research
- Cell Biology
- Pulmonary Medicine
Background:
- Pulmonary hypertension (PH) is a severe condition with high mortality.
- PH pathogenesis involves vascular remodeling, elevated pressure, and right heart failure.
- Endothelial cell (EC) dysfunction is a key factor in PH, regardless of the cause.
Purpose of the Study:
- To review the role of caveolin-1 disruption and dysfunction in the pathogenesis of PH.
- To differentiate the mechanisms of PH in EC-disruptive versus hypoxia-induced models.
Main Methods:
- Review of clinical and experimental studies on PH.
- Analysis of the role of endothelial caveolin-1 in PH pathogenesis.
- Comparison of PH mechanisms in different experimental models.
Main Results:
- EC disruption leads to caveolin-1 loss, activating proliferative and inflammatory pathways, driving PH.
- Enhanced caveolin-1 expression in smooth muscle cells (SMCs) promotes neointima formation.
- Hypoxia-induced PH involves caveolin-1 dysfunction without EC disruption, and is reversible upon hypoxia removal if ECs are intact.
Conclusions:
- Caveolin-1 plays a critical role in PH, both through disruption-induced loss and hypoxia-induced dysfunction.
- Understanding caveolin-1's role is crucial for developing targeted PH therapies.
- Distinguishing between PH mechanisms is important for predicting reversibility and treatment response.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

